Arcadia Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Arcadia Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,000	Closed	-$19K	–	289
2020 Q4	$19K	Hold	1,000	–	–	﹤0.01%	223
2020 Q3	$17K	Hold	1,000	–	–	﹤0.01%	244
2020 Q2	$23K	Hold	1,000	–	–	0.01%	225
2020 Q1	$8K	Hold	1,000	–	–	﹤0.01%	272
2019 Q4	$10K	Hold	1,000	–	–	﹤0.01%	264
2019 Q3	$9K	Hold	1,000	–	–	﹤0.01%	275
2019 Q2	$12K	Hold	1,000	–	–	﹤0.01%	287
2019 Q1	$18K	Hold	1,000	–	–	0.01%	248
2018 Q4	$17K	Sell	1,000 -1,000	-50%	-$17.1K	0.01%	243
2018 Q3	$30K	Hold	2,000	–	–	0.01%	254
2018 Q2	$32K	Hold	2,000	–	–	0.01%	253
2018 Q1	$28K	Hold	2,000	–	–	0.01%	265
2017 Q4	$28K	Buy	+2,000	New	+$29.3K	0.01%	274
2017 Q1	–	Sell	-2,000	Closed	-$35K	–	444
2016 Q4	$35K	Buy	+2,000	New	+$35.1K	0.01%	228

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Arcadia Investment Management's VIVO Position: Q1 2021 in Review

Arcadia Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2021, closing a stake of 1,000 shares — an estimated $19K sold.

Arcadia Investment Management first reported a position in VIVO in Q4 2016 and held it in 14 quarters. The position peaked at $35K in Q4 2016. 215 funds tracked by Wall St. Rank hold VIVO as of Q1 2021.

Arcadia Investment Management reported no remaining Meridian Bioscience Inc position as of Q1 2021 after selling out during the quarter.
Arcadia Investment Management sold 1,000 Meridian Bioscience Inc shares in Q1 2021, an estimated $19K.
Arcadia Investment Management first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 14 quarters.
Arcadia Investment Management's Meridian Bioscience Inc position peaked at $35K in Q4 2016.
215 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2021.

Based on Arcadia Investment Management's 13F filing for Q1 2021, filed 30 Apr 2021.